European Journal of Radiology
Volume 64, Issue 3 , Pages 432-438 , December 2007

Comparison of magnetic resonance imaging and 67gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma

Received 13 June 2005 ,Revised 26 October 2006 ,Accepted 8 March 2007.

References 

  1. Canini R, Battista G, Monetti N, et al. Bulky mediastinal lymphomas: role of magnetic resonance and SPECT-Ga-67 in the evaluation of residual masses. Radiol Med. 1995;90(4):448–456
  2. Klein J, Král V, Neoral Č, Faber E. Torakoskopická diagnostika mediastinálních lymfomů. Vnitr Lek. 1997;43(12):787–789
  3. Klein J, Král V, Neoral Č. Invazivní metody v diagnostice novotvarů mediastina. Rozhl Chir. 1998;77(6):249–251
  4. Bonomo L, Coccotosto C, Guidotti A, Merlino B, Storto ML. Staging of thoracic lymphoma by radiological imaging. Eur Radiol. 1997;7(8):1179–1189
  5. Brenot-Rossi I, Bouabdallah R, Di Stefano D, et al. Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy. Eur J Nucl Med. 2001;28(10):1482–1488
  6. Devizzi L, Maffioli L, Bonfante V, et al. Comparison of gallium scan, computed tomography and magnetic resonance with mediastinal Hodgkin's disease. Ann Oncol. 1997;8(Suppl. 1):53–56
  7. Chajari MH, Lacroix J, Peny AM, et al. Gallium-67 scintigraphy in lymphoma: is there a benefit of image fusion with computed tomography?. Eur J Nucl Med. 2002;29(3):380–387
  8. Gasparini MD, Balzarini L, Castellani MR, et al. Current role of gallium and magnetic resonance imaging in the management of mediastinal Hodgkin's lymphoma. Cancer. 1993;72(2):577–582
  9. Rahmouni A, Divine M, Lepage E, et al. Mediastinal lymphoma: quantitative changes in gadolinium enhancement at MR imaging after treatment. Radiology. 2001;219(3):621–628
  10. Nyman R, Forsgren G, Glimelius B. Long-term follow-up of residual mediastinal masses in treat Hodgkin's disease using MR imaging. Acta Radiol. 1996;37(3):323–326
  11. Pannu HK, Wang KP, Borman TL, Bluemke DA. MR imaging of mediastinal lymph nodes: evaluation using a superparamagnetic contrast agent. J Magn Reson Imaging. 2000;12(6):899–904
  12. Rahmouni A, Tempary C, Jones R, Mann R, Yang A, Zerhouni E. Lymphoma: monitoring tumor size and signal intensity with MR imaging. Radiology. 1993;188(2):445–451
  13. Di Cesare E, Cerone G, Enrici RM, et al. MR characterization of residual masses in Hodgkin's disease: long-term follow-up. Magn Reson Imaging. 2004;22(1):31–38
  14. Jeruzalem G, Warland V, Najjar F, et al. Whole-body 18F-FDG PET for the evaluation patients with Hodgkin's disease and non-Hodgkin's lymphoma. Nucl Med Commun. 1999;20(1):13–20
  15. Jerusalem G, Beguin Y, Fassotte MF, et al. Early detection of relapse by whole body positron emission tomography in the follow-up of patients with Hodgkin's disease. Ann Oncol. 2003;14(1):123–130

PII: S0720-048X(07)00140-4

doi: 10.1016/j.ejrad.2007.03.003

European Journal of Radiology
Volume 64, Issue 3 , Pages 432-438 , December 2007

Article Tools

* Image Usage & Resolution